Ziye Sui

Ziye Sui is currently the Chief Executive Officer at Lepu Hushengtang Internet Technology Co. Ltd.
She is also the Chief Executive Officer & Executive Director at Lepu Biopharma Co., Ltd., the Director at Shanghai Miracogen, Inc., the Director at Taizhou Houde Aoke Technology Co. Ltd., the Director at Hangzhou Healsun Biopharma Co. Ltd., the Director at Hangzhou Xiyuan Biotechnology Co. Ltd., the Executive Director at CtM Bio Co., Ltd., and the General Manager at Lepu Beijing Biopharma Co. Ltd.
Previously, Dr. Sui held the position of Chief Executive Officer at Beijing Lepu Hushengtang Technology Co. Ltd.
from 2015 to 2019.
She was also the Chairman at Hainan MSD Pharmaceutical Co., Ltd.
from 2015 to 2020, the Non-Executive Director at Star Combo Pharma Ltd.
from 2018 to 2022, the Executive Director at Beijing Star GK Medical Device Co. Ltd.
from 2017 to 2020, the Director at Beijing Quinovare Medical Technology Co. Ltd.
from 2016 to 2020, and the VP, Manager-International Sales & Marketing at Lepu Medical Technology (Beijing) Co., Ltd.
from 2007 to 2020.
Additionally, she served as the Chief Executive & Technology Officer at Comed BV from 2012 to 2015.
Dr. Sui obtained a doctorate degree from Rochester Christian University in 2007 and an undergraduate degree from Peking University in 2001.